1. Home
  2. JZ vs ONCO Comparison

JZ vs ONCO Comparison

Compare JZ & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

HOLD

Current Price

$1.33

Market Cap

12.1M

Sector

Real Estate

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$2.03

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JZ
ONCO
Founded
2011
2018
Country
China
United States
Employees
46
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
4.3M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
JZ
ONCO
Price
$1.33
$2.03
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.8K
37.9K
Earning Date
10-16-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,589,020.00
$1,223,751.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$2.10
52 Week High
$14.60
$179.35

Technical Indicators

Market Signals
Indicator
JZ
ONCO
Relative Strength Index (RSI) 29.69 35.76
Support Level $1.38 $2.53
Resistance Level $1.44 $3.22
Average True Range (ATR) 0.02 0.33
MACD 0.00 -0.03
Stochastic Oscillator 0.00 7.58

Price Performance

Historical Comparison
JZ
ONCO

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: